Spinal Procedures Benefit From Medical Innovations
17 Oct 2012
Back problems are fast becoming a global epidemic, as aging populations, obesity, and conditions such as cancer or osteoporosis lead many individuals to injure their spines, and develop Vertebral Compression Fractures (VCFs), states a new report by healthcare experts GlobalData.
Vertebroplasty and vertebral augmentation consist of the insertion of bone cement into fractured vertebrae using a special needle. The new report* states that these treatments are likely to become more popular over coming years, due to the launch of new technologies.
Vertebroplasty device manufacturers have launched new devices which offer more precise bone cement delivery techniques, reducing the probability of bone cement leakage and subsequent fracture among patients.
In addition to better delivery mechanisms, the vertebroplasty manufacturers are also exploring opportunities to develop alternatives to poly(methyl methaacrylate) (PMMA), which is currently used as bone cement in most of the procedures. PMMA used commonly in both vertebroplasty and vertebral augmentation has a tendency to leak from the crevices, particularly in vertebroplasty procedures. This results in increased risk of subsequent fractures as well as contributing to pain.
To counter this problem, vertebroplasty device manufacturers are exploring various alternatives to PMMA such as bio-ceramic bone cement, composite resin cement (such as Cortoss by Orthovita), calcium phosphate and calcium sulfate cement, carbonated hydroxyapatite cement, partially absorbable bone cement (Cerament by BoneSupport) and so on. New PMMA formulations are also explored as an alternative. These new filler materials have the potential to show better biocompatibility, biomechanical strength and radiopacity (for fluoroscopic guided procedures) than previously used PMMA formulations.
The global vertebral augmentation and vertebroplasty devices market was valued at $981.8m in 2011 and is forecast to grow at Compound Annual Growth Rate (CAGR) of 12.6% in the 2011–2018 period.
NOTES TO EDITORS
This report gives an overview of vertebral compression fracture, treatment modalities and major vertebral compression fracture treatment segments. Key segments covered include vertebral augmentation devices (referred as balloon kyphoplasty devices in some places) and vertebroplasty devices. The report also gives annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018, pipeline analysis split across different phases, and profiles of key products that are under clinical development.This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.
GlobalData is the premier source of actionable insight into the energy and healthcare industries.
With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide
high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase
For further details, please Contact Us.
Subscribe to our RSS Feed: